Centene Corporation’s stock fell after reporting mixed fiscal 2026 outlook. The company’s Q4 2025 adjusted loss beat consensus, but sales guidance for 2026 fell short. Total membership declined driven by Medicaid, though commercial membership increased.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Centene Takes A Hit As Medicaid Membership Shrinks
Centene Corporation’s stock fell after reporting mixed fiscal 2026 outlook. The company’s Q4 2025 adjusted loss beat consensus, but sales guidance for 2026 fell short. Total membership declined driven by Medicaid, though commercial membership increased.